TY - BOOK ID - 40138199 TI - FTO (freedom to operate) in the pharmaceutical industry PY - 2018 SN - 3845294019 3848752212 PB - Nomos Verlagsgesellschaft mbH & Co. KG DB - UniCat KW - Drugs KW - Patent medicines KW - Patents. KW - Law and legislation. KW - Law and legislation KW - FTO KW - pharmaceutical industry KW - Freedom to Operate KW - antitrust law KW - FTO-licensing market KW - Patent KW - License KW - Pharmaceutical KW - EU competition law UR - https://www.unicat.be/uniCat?func=search&query=sysid:40138199 AB - FTO licensing in the pharmaceutical industry deserves special consideration because of the large economic scale of the market, expensive cost of R&D, extremely low success rate, and easy duplication of the drug. Taking these unique aspects into consideration, the author first explaines how to perform a good FTO search and conclude an appropriate FTO licensing agreement, and then points out two issues; (i) the issue of FTO licensing and EU competition, especially the unreasonable application of the Guideline, and (ii) the issue of FTO licensing and differentiating between a bio venture company and a pharmaceutical company. Solutions for these issues are proposed. ER -